Skip to main content
. Author manuscript; available in PMC: 2022 Feb 8.
Published in final edited form as: Curr Biol. 2020 Nov 30;31(3):650–657.e3. doi: 10.1016/j.cub.2020.10.092

Table 2.

Comparison of Change Values in Weight, Metabolic Markers, and Fasting Hormone and Metabolites Between Conditions

Daytime Condition Delayed Condition Analyses
t-test Effect Size
Pre- Post- Pre- Post-
OUTCOME MEASURES Mean (SD) Mean (SD) t p d
Weight and Metabolic Markers
Weight (kg) 65.4 (7.5) 64.3 (7.6) 64.8 (7.5) 65.0 (8.0) −1.976 0.074 0.571
Resting Energy Expenditure (kcals) 1570.9 (214.5) 1477.3 (230.1) 1563.2 (214.5) 1587.6 (138.0) −1.783 0.100 0.515
Respiratory Quotient (CO2 eliminated/O2 consumed) 0.84 (0.05) 0.83 (0.04) 0.81 (0.06) 0.84 (0.07) −1.571 0.140 0.454
DXA Total Fat (%) 27.6 (5.4) 27.9 (5.0) 28.0 (5.4) 27.6 (5.0) 1.647 0.130 0.476
DXA Lean Mass (%) 14.5 (2.0) 14.7 (1.9) 14.7 (1.9) 15.0 (2.2) −0.673 0.510 0.194
DXA Trunk Fat (%) 26.1 (5.3) 25.7 (5.1) 25.7 (5.3) 25.6 (5.1) −1.068 0.310 0.308
DXA Trunk/Leg Fat (%) 0.87 (0.11) 0.85 (0.10) 0.85 (0.11) 0.87 (0.11) −3.530 0.005 1.019
Fasting Hormones and Metabolites*
Total Cholesterol (mg/dL) 159.8 (29.1) 155.9 (28.2) 157.6 (38.0) 162.0 (34.2) −1.416 0.184 0.409
dHDL Cholesterol (mg/dL) 57.4 (12.6) 53.8 (9.1) 56.3 (15.5) 60.0 (16.8) −2.536 0.028 0.732
LDL Cholesterol (mg/dL) 87.9 (24.6) 87.8 (25.7) 86.2 (32.6) 83.7 (31.2) 1.857 0.090 0.536
Triglycerides (mg/dL) 71.8 (19.2) 73.3 (32.7) 78.4 (12.6) 93.4 (46.9) −1.895 0.085 0.547
Adiponectin (ug/ml) 17.7 (8.3) 17.4 (6.3) 17.4 (6.7) 21.4 (6.6) −1.376 0.196 0.397
NEFA (mEq/L) 0.33 (0.14) 0.39 (0.13) 0.40 (0.14) 0.31 (0.19) 1.413 0.185 0.408
Glucose (mg/dL) 95.3 (7.4) 91.6 (11.6) 92.1 (5.3) 97.0 (12.7) −1.733 0.111 0.500
Insulin (ulU/ml) 8.1 (3.0) 7.1 (3.2) 6.8 (2.3) 7.8 (3.5) −1.926 0.080 0.556
HOMA-IR 1.92 (0.72) 1.66 (0.97) 1.54 (0.49) 1.84 (0.80) −2.252 0.046 0.650

Note: p=p-value from paired t-tests; d=Cohen’s d;

*

Analyses are adjusted for weight change.

A fasting blood draw was taken at 0800h after a minimum 9h fasting period.

DXA – dual-energy x-ray absorptiometry; dHDL – direct high-density lipoprotein; LDL – low-density lipoprotein; NEFA – non-esterified fatty acid; HOMA-IR – Homeostatic Model Assessment of Insulin Resistance